Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Prashanth KS et al. | 2009 | isolated bio./chem. substance, acid phosphatase | magnetic field, 50/60 Hz, co-exposure | 0.53 mT |
| Luo X et al. | 2016 | animal, mouse/ICR, whole body | magnetic field, 50/60 Hz, co-exposure | 2–10 mT |
| Cecerska-Heryć E et al. | 2024 | human plasma samples | magnetic field, 50/60 Hz, low frequency | - |
| Amirahmadi F et al. | 2023 | intact cell/cell culture, rat bone marrow-derived stem cells | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
| Litovitz TA et al. | 1994 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz, power transmission line | 10–100 µT |
| Mahmood M et al. | 2013 | plant, oil palm (<i>Elaeis guineensis</i> Jacq.) | magnetic field, 50/60 Hz, power transmission line, electric field | - |
| Cress LW et al. | 1999 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 10 µT |
| Woods M et al. | 2000 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) and NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 46–100 µT |
| Dibirdik I et al. | 2000 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) and NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
| Nie K et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line), MCF-7 cells (breast cancer cell line), 3Y1 cells (rat fibroblast cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
